BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 21, 2025
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
Positive phase I results for new formulation of lexipafant
March 12, 1997
Gene linked to juvenile macular degeneration cloned
March 7, 1997
Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.
March 6, 1997
Medarex acquires Houston Biotechnology
March 5, 1997
Dorzolamide and timolol alone and in combination for glaucoma
March 4, 1997
AEterna codevelopment agreement for AE-941
Feb. 27, 1997
Bio-Technology General grants license to BioLon in Japan
Feb. 26, 1997
Comparative trial of dorzolamide and acetazolamide
Feb. 21, 1997
Alcon describes dihydropyridines for ocular use
Feb. 21, 1997
U.K. launch for P&U glaucoma Rx
Feb. 19, 1997
Previous
1
2
…
377
378
379
380
381
382
383
384
385
386
387
Next